These lab-designed possibilities were not created with leisure use in your mind. During the 1990s, John W. Huffman and a team of fellow chemists at Clemson College designed a few of the first formulation for artificial cannabinoid receptor agonists (SCRAs), a relatives of substances that imitate the physiological and psychological impacts of cannab